Infectious Disorders - Drug Targets

Formerly Current Drug Targets - Infectious Disorders


Jean-Marc Sabatier
Laboratoire ERT 62 'Ingénierie des peptides à visée thérapeutique'
Université de la Méditerranée
Faculté de Médecine Nord
Boulevard Pierre Dramard
13916 - MARSEILLE, Cedex 20

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Discovery and Development of VX-950, a Novel, Covalent, and Reversible Inhibitor of Hepatitis C Virus NS3.4A Serine Protease open Access plus

Volume:6   Issue: 1
Pp: 3-16
C. Lin, A. D. Kwong and R. B. Perni
DOI: 10.2174/187152606776056706

Nucleoside Analog Inhibitors of Hepatitis C Virus Replication open Access plus

Volume:6   Issue: 1
Pp: 17-29
S. S. Carroll and D. B. Olsen
DOI: 10.2174/187152606776056698

Allosteric Inhibition of the Hepatitis C Virus NS5B RNA Dependent RNA Polymerase open Access plus

Volume:6   Issue: 1
Pp: 31-41
Uwe Koch and Frank Narjes
DOI: 10.2174/187152606776056724

Future Promise of siRNA and Other Nucleic Acid Based Therapeutics for the Treatment of Chronic HCV open Access plus

Volume:6   Issue: 1
Pp: 43-56
J. A. Wilson and C. D. Richardson
DOI: 10.2174/187152606776056689

Chronic Hepatitis C in HIV-Infected Patients: Those Who More Need Therapy are Those Who Respond Less open Access plus

Volume:6   Issue: 1
Pp: 57-68
Vincent Soriano, Marina Nunez, Javier Garcia-Samaniego, Pablo Labarga, Nuria Simarro, Luz Martin-Carbonero, Miriam Romero, Belen Ramos and Pablo Barreiro
DOI: 10.2174/187152606776056715